J. Stern & Co. LLP, a registered investment adviser, initiated a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 2,653,351 shares of the Healthcare company, valued at approximately $2.7B as of the filing date.
IDEXX Laboratories, Inc.'s stock currently trades at $630.25 with a market capitalization of $56.5B.
